3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Interventions
fludarabine phosphate
24
Peripheral Blood Stem Cell Transplantation
21
Cyclophosphamide
21
Busulfan
19
Whole-Body Irradiation
15
Tacrolimus
15
Mycophenolic Acid
13
Methotrexate
12
ruxolitinib
11
Cyclosporine
10
Antilymphocyte Serum
10
fludarabine
8
Melphalan
7
peginterferon alfa-2a
6
Aspirin
6
Filgrastim
5
Stem Cell Transplantation
4
Radiotherapy
4
Imatinib Mesylate
4
Hydroxyurea
4
Flow Cytometry
4
Etoposide
4
Decitabine
4
Biopsy
4
Azacitidine
4
Thiotepa
3
Surveys and Questionnaires
3
Prednisone
3
Methylprednisolone
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polycythemia Vera
×
N(4)-oleylcytosine arabinoside
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled